Skip to main content
Premium Trial:

Request an Annual Quote

IU Med School, Imgen, Barlett-Williams, Syngene, MDS, Waters

Premium
New Facility at IU Med School to use Proteomics for Cancer Research
 
A new research facility at the Indiana University School of Medicine, South Bend, will use proteomic and genomics technologies for cancer biology research, the school said last week.
 
Harper Hall, to be built with $10 million in state funding and $10 million in a personal gift, will include offices and laboratory space for IUSM-SB and the University Notre Dame’s cancer research work.
 
The gift, in the amount of $10 million, is from Charles Harper, the retired chair and CEO of ConAgra foods and RJR Nabisco, and made in memory of his late wife Josie.
 

 
Imgen, Barlett-Williams Sells Syngene Products
 
UK-based image-analysis firm Syngene said last week that Imgen and Bartlett-Williams will market and sell its gel documentation and image analyzer range Dyversity and Dymension 2D systems.
 
The appointments were made to increase Syngene’s presence in the US, company officials said in a statement.
 
Bartlett-Williams distributes consumables, disposables, and capital equipment to cell biology and microbiology researchers. Imgen offers sales and support to molecular bilogy and life science product manufacturers.
 
Terms of the deals were not disclosed.
 

 
MDS to buy Back 4.5 Million Shares
 
MDS this week said the Toronto Stock Exchange has accepted its notice of intention to buy back up to 4.5 million of its common shares over the next 12 months.
 
The potential buyback relates to MDS’ shares that trade on the Toronto exchange and will not affect the company’s shares that trade on the New York Stock Exchange.
 
As of June 26, MDS had 122.5 million shares issued and outstanding on the Toronto Stock Exchange.
 

 
Waters Ships SMDS Vision Publisher
 
Waters announced this week it is shipping SDMS Vision Publisher for its NuGenesis Scientific Data Management System, a secure electronic repository that stores and manages scientific data to a centralized database.
 
Using the Vision Publisher along with NuGenesis, researchers can electronically capture primary data from a variety of laboratory devices and instruments and append the information and associated metadata to the experimental record, Waters said in a statement.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.